Deep Medicine Acquisition Corp. (NASDAQ:DMAQ – Get Rating) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totalling 10,100 shares, a decrease of 19.2% from the July 15th total of 12,500 shares. Currently, 0.1% of the company's stock are sold short. Based on an average trading volume of 16,800 shares, the days-to-cover ratio is presently 0.6 days.

Deep Medicine Acquisition Price Performance

NASDAQ DMAQ opened at $10.03 on Friday. Deep Medicine Acquisition has a 1-year low of $9.70 and a 1-year high of $10.99. The firm's fifty day simple moving average is $10.01 and its 200-day simple moving average is $9.97.

Institutional Investors Weigh In On Deep Medicine Acquisition

Large investors have recently bought and sold shares of the business. Oaktree Capital Management LP acquired a new position in shares of Deep Medicine Acquisition during the fourth quarter valued at about $4,173,000. Saba Capital Management L.P. acquired a new position in Deep Medicine Acquisition in the fourth quarter worth about $8,908,000. Arena Investors LP acquired a new position in Deep Medicine Acquisition in the first quarter worth about $59,000. Bluefin Capital Management LLC acquired a new stake in shares of Deep Medicine Acquisition during the fourth quarter worth approximately $147,000. Finally, Beryl Capital Management LLC acquired a new stake in shares of Deep Medicine Acquisition during the fourth quarter worth approximately $6,012,000. 71.22% of the stock is currently owned by institutional investors.

Deep Medicine Acquisition Company Profile

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry.

Read More

• Get a free copy of the StockNews.com research report on Deep Medicine Acquisition (DMAQ)
• 2 Important Retail Stock Battles to Watch
• MarketBeat: Week in Review 8/8 – 8/12
• What Is WallStreetBets and What Stocks Are They Targeting?
• Institutions And Analysts Propel Jack In The Box Higher
• Can You Guess Which EV Stock Is Beating Tesla ?

Receive News & Ratings for Deep Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deep Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.